The Chemours Company
CC
$20.22
-$0.64-3.07%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -411.00M | -387.00M | -338.00M | -430.00M | 10.00M |
| Total Depreciation and Amortization | 342.00M | 351.00M | 321.00M | 315.00M | 309.00M |
| Total Amortization of Deferred Charges | 11.00M | 11.00M | 12.00M | 12.00M | 12.00M |
| Total Other Non-Cash Items | 79.00M | 111.00M | 120.00M | 180.00M | 60.00M |
| Change in Net Operating Assets | 311.00M | 178.00M | 150.00M | 181.00M | -846.00M |
| Cash from Operations | 332.00M | 264.00M | 265.00M | 258.00M | -455.00M |
| Capital Expenditure | -178.00M | -213.00M | -277.00M | -312.00M | -342.00M |
| Sale of Property, Plant, and Equipment | 14.00M | 7.00M | 7.00M | 1.00M | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 1.00M | 4.00M |
| Cash from Investing | -164.00M | -206.00M | -270.00M | -310.00M | -338.00M |
| Total Debt Issued | 1.52B | 828.00M | 791.00M | 794.00M | 699.00M |
| Total Debt Repaid | -1.55B | -889.00M | -703.00M | -703.00M | -607.00M |
| Issuance of Common Stock | 2.00M | -- | 1.00M | 1.00M | 8.00M |
| Repurchase of Common Stock | -2.00M | -1.00M | -1.00M | -1.00M | -2.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -54.00M | -78.00M | -99.00M | -124.00M | -148.00M |
| Other Financing Activities | -2.00M | 14.00M | 7.00M | 7.00M | 11.00M |
| Cash from Financing | -88.00M | -126.00M | -4.00M | -26.00M | -39.00M |
| Foreign Exchange rate Adjustments | 21.00M | 29.00M | 8.00M | 12.00M | -7.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.00M | -39.00M | -1.00M | -66.00M | -839.00M |